Literature DB >> 6284650

[Penetration of ceftizoxime (FK 749) into the cerebrospinal fluid (author's transl)].

B Ruf.   

Abstract

After the cytology and the chemistry of the CSF had returned to normal, the concentration of ceftizoxime was determined in the CSF and in the serum of 27 patients who had suffered from purulent or serous meningitis. The patients were divided into four groups. The concentration in the CSF was mean = 0.87 mg/l two hours after a bolus injection of 2 g ceftizoxime. After an infusion of 2 g ceftizoxime over 30 minutes, the concentration in the CSF was mean = 0.32 mg/l one hour and mean = 0.99 mg/l two hours after the infusion was started. The highest concentrations in the CSF were obtained six hours after a bolus injection of 2 g ceftizoxime. The peak value was 4.3 mg/l and the mean 1.78 mg/l. Based on these pharmacokinetic data, additional injections could have a cumulative effect on the concentration of ceftizoxime in the CSF. With the exception of Staphylococcus sp., Pseudomonas sp. and some anaerobes, it can be expected that ceftizoxime will be effective against other organisms causing meningitis. The results of clinical applications remain to be seen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284650     DOI: 10.1007/bf01816728

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  16 in total

1.  [Cerebrospinal-fluid affinity of cefoxitin].

Authors:  B Oellers; O Müller; K Fabricius; J Berlin
Journal:  MMW Munch Med Wochenschr       Date:  1979-04-13

2.  [Various aspects of the pharmacokinetics of Celospor with special reference to its affinity to cerebrospinal fluid].

Authors:  H G Meyer-Brunot; C Schenk; K Schmid; P Spring; W Theobald; J Wagner
Journal:  Wien Med Wochenschr Suppl       Date:  1975

Review 3.  [Purulent meningitis. Pathogenesis, diagnosis and therapy].

Authors:  H Rosin
Journal:  Dtsch Med Wochenschr       Date:  1979-09-07       Impact factor: 0.628

Review 4.  The penetration of antibiotics into cerebrospinal fluid and brain tissue.

Authors:  R W Barling; J B Selkon
Journal:  J Antimicrob Chemother       Date:  1978-05       Impact factor: 5.790

5.  Development of meningitis during cephalothin therapy.

Authors:  R J Mangi; R S Kundargi; R Quintiliani; V T Andriole
Journal:  Ann Intern Med       Date:  1973-03       Impact factor: 25.391

6.  [Investigations on the penetration of cefamandole into spinal fluid (author's transl)].

Authors:  B Oellers; O Müller; K Fabricius; J Ungemach
Journal:  Infection       Date:  1978       Impact factor: 3.553

7.  The penetration of cefuroxime into the cerebrospinal fluid through inflamed and non-inflamed meninges.

Authors:  C Müller; A Netland; A F Dawson; E Andrew
Journal:  J Antimicrob Chemother       Date:  1980-03       Impact factor: 5.790

8.  Investigations of cefuroxime levels in cerebrospinal fluid of patients with and without meningitis.

Authors:  H Friedrich; G Haensel-Friedrich; H Langmaak; F D Daschner
Journal:  Chemotherapy       Date:  1980       Impact factor: 2.544

9.  Lack of penetration of cephacetril into the cerebro-spinal fluid of patients without meningitis.

Authors:  H Friedrich; K Pelz; G Hänsel-Friedrich
Journal:  Infection       Date:  1979       Impact factor: 3.553

10.  Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.

Authors:  U B Schaad; G H McCracken; N Threlkeld; M L Thomas
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

View more
  2 in total

1.  Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?

Authors:  J T Noble; M Barza
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 2.  Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R C Heel
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.